Language: English

Threads containing posts by Natuli

 

3	1499	deputy Qualified Person  pharm.	Natuli	14.07.2010	0:29
4	284	use at potency  pharm.	Natuli	13.07.2010	15:44
2	124	Pharmacokinetic parameters to be estimated based on activity  clin.trial.	Natuli	6.07.2010	17:09
2	120	action  clin.trial.	Natuli	6.07.2010	16:47
3	188	conditional visit  clin.trial.	Natuli	6.07.2010	16:02
2	142	binding antibodies against Х as well as cross-reacting binding antibodies to ХУ and two analyses of ...  clin.trial.	Natuli	6.07.2010	8:45
2	242	extensive in vitro characterization tests and specification analyses have been compared  clin.trial.	Natuli	6.07.2010	8:37
2	231	проверьте пожалуйста, перевод  med.	Natuli	6.07.2010	8:36
5	186	internal safety assessment  clin.trial.	Natuli	5.07.2010	17:51
5	436	assumption of approximate log linear Х activities in the initial phase  clin.trial.	Natuli	5.07.2010	17:22
2	219	bypassing agent  med.	Natuli	4.07.2010	22:05
6	427	exceptional outliers  clin.trial.	Natuli	4.07.2010	13:59
2	153	normal distribution approximation of logAUC  clin.trial.	Natuli	3.07.2010	19:19
4	189	as part of the Database Lock DBL minutes  clin.trial.	Natuli	3.07.2010	15:41
4	172	Insert local data protection requirements, if applicable	Natuli	27.06.2010	22:21
7	925	Please refer	Natuli	26.06.2010	15:28
9	259	your name and identity will not be recorded or revealed	Natuli	26.06.2010	11:47
13	232	with 4 or 12 daily dose withdrawals respectively for the two strengths  pharm.	Natuli	31.05.2010	16:50
2	337	protected with nitrogen  pharm.	Natuli	30.05.2010	18:12
8	576	Back filling with nitrogen prior to stoppering  pharm.	Natuli	30.05.2010	18:11
3	151	tubing  pharm.	Natuli	30.05.2010	18:09
8	336	дело номер хххх  med.	redseasnorkel	30.05.2010	12:45
4	712	the vacuum is broken with sterile nitrogen before the stoppers  pharm.	Natuli	30.05.2010	11:17
2	123	both studies were representative for  pharm.	Natuli	27.05.2010	19:03
2	141	based on the anticipated human doses  med.	Natuli	27.05.2010	19:02
2	159	The containers will be stored up-right.  pharm.	Natuli	26.05.2010	14:57
6	545	HVD  pharm.	Natuli	25.05.2010	16:32
3	201	in-house periods  clin.trial.	Natuli	25.05.2010	12:14
22	1290	пациент healthy male  clin.trial.	Natuli	25.05.2010	11:40
7	453	6 active and 2 placebo  clin.trial.	Natuli	25.05.2010	11:28
8	223	formal statistical analyses  clin.trial.	Natuli	24.05.2010	11:57

Pages 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21